How does Thymalin's half-life affect dosing?

Thymalin has a plasma half-life of Variable, which is moderate, supporting once-daily dosing in most protocols. The receptor occupancy curve under daily for 10-day cycles, 1-2x yearly dosing at 5-10 mg per dose explains the typical onset timeline for scheduling and cycle endpoints.

Is Thymalin safe during pregnancy or breastfeeding?

Thymalin, like most non-approved peptide therapeutics, does not have safety data supporting use during pregnancy or lactation. The default position is contraindication during pregnancy, lactation, and active conception, with discontinuation at least 2–3 cycles before planned conception. Approved indications (where they exist) may have specific guidance — verify with the prescribing physician.

What is the standard dosing protocol for Thymalin?

Conventional Thymalin dosing is 5-10 mg daily for 10-day cycles, 1-2x yearly via im/subq. For scheduling and cycle use specifically, the cycle pattern is typically 8–12 weeks on followed by a 4 week off-period. Higher doses are studied in advanced protocols but produce diminishing dose-response in the published literature.

How should Thymalin be stored and reconstituted?

Lyophilised Thymalin stores at −20°C for 18–24 months. After reconstitution with bacteriostatic water, the solution holds at 4°C for 14–28 days. Avoid freeze-thaw cycles of reconstituted material. Travel with cold packs in insulated containers; avoid prolonged exposure above 25°C. The standard reconstitution concentration is 1–2 mg/mL depending on the vial size.

How long until I see results from Thymalin?

Acute effects from Thymalin appear within the first week for downstream physiological adaptation. scheduling and cycle endpoints accumulate across 4–8 weeks; the typical 8–12 week cycle is calibrated to allow the full response window. Single-week evaluations consistently underestimate the response trajectory.

Home/ Compounds/ Thymalin

Thymalin

Protocol

Scheduling Thymalin alongside existing protocols, training, and lifestyle inputs requires understanding the compound's pharmacokinetic constraints and the cycle calendar. A complex of low-molecular-weight thymic polypeptides used in Russian clinical research for decades — immunomodulation, anti-aging, and supportive care in chronic disease. Daily timing relative to meals and training, weekly cycle structure, and integration with stack components on independent pathways are the three layers of the protocol calendar developed below.

Protocol / Scheduling / Cycling Applications

Protocol CalendarOff-TimeWeekly TimingWash-OutStack Scheduling

Key Takeaways

Scheduling lens: Thymalin's Variable half-life via im/subq places it in the daily-dosing bucket.
Mechanism: Influences T-cell maturation and immune function.
Cycle structure: 8-12 weeks on, 4 weeks off; the off-period is functionally required for receptor reset.
Stack scheduling: add one compound at a time with 2 weeks of isolated dosing before layering.
Schedule-compatible stack partners: BPC-157, TB-500, Ipamorelin.

Protocol / Scheduling / Cycling Mechanism

Protocol calendar planning for Thymalin is shaped by mechanism, pharmacokinetics, and operational reality. Influences T-cell maturation and immune function. Modulates expression of thymic-derived cytokines. Part of Khavinson's broader peptide bioregulator framework for tissue-specific transcriptional regulation. The subsections below work through the daily timing patterns, the 8-12 week cycle structure with calibrated off-period, the stack scheduling principles, and the travel-and-disruption playbook.

Cycle length and off-cycle planning

Standard Thymalin cycle length is 8–12 weeks for most users, with off-cycle periods of 4–6 weeks calibrated to allow receptor sensitivity to recover and any cumulative downregulation to resolve. The off-cycle is not optional in well-designed protocols; it is the period during which the dose response is reset for the next cycle.

Travel, schedule shifts, and continuity

Maintaining cycle continuity through travel, time-zone shifts, and irregular schedules is one of the practical considerations for any Thymalin protocol. Cold-chain requirements (where applicable), customs considerations for international travel, and adjustment for time-zone shifts within a 24–48 hour window are the main operational issues. For most Thymalin schedules a ±8-hour timing shift has no clinical effect; longer shifts warrant minor schedule adjustment.

Stack scheduling with other compounds

When Thymalin is part of a multi-compound stack, the scheduling question becomes how to time its dose relative to the others. Multiple subcutaneous compounds can be combined in a single injection where compatible, or staggered through the day where pharmacokinetics differ meaningfully. The pragmatic schedule reflects both pharmacokinetic constraints and the user's operational reality.

Protocol / Scheduling / Cycling Applications

Stack Scheduling

The most-asked scheduling question for Thymalin in stack scheduling is when to time doses relative to meals and training. The general principle: fasted dosing for compounds engaging the GH axis or AMPK; meal-paired dosing for incretins; flexibility for compounds whose pharmacokinetics permit it.

Off-Time

Schedule design for Thymalin in off-time starts from pharmacokinetic constraints: less frequent dosing for long half-life compounds. The cycle length and off-period are then layered on top of the daily schedule.

Tapered Cycles

For tapered cycles scheduling, Thymalin is best run in 8–12 week cycles with 4 week off-periods. Daily timing within the cycle is calibrated to pharmacokinetics; weekly timing is calibrated to training and lifestyle constraints. The schedule is the protocol.

Maintenance Phase

The most-asked scheduling question for Thymalin in maintenance phase is when to time doses relative to meals and training. The general principle: fasted dosing for compounds engaging the GH axis or AMPK; meal-paired dosing for incretins; flexibility for compounds whose pharmacokinetics permit it.

Dosing Protocol

Goal	Route	Dose	Cycle
Standard protocol	IM	5-10 mg	8–12 weeks on / 4 weeks off
Conservative starter	IM	3-10 mg	4–6 weeks initial cycle
Protocol focus	IM	5-10 mg	Daily for 10-day cycles, 1-2x yearly
Maintenance phase	IM	4-10 mg	Ongoing with periodic pauses

Dose timing for Thymalin is less time-sensitive given the longer half-life. Consistency through the cycle is more important than the precise clock time of individual doses.

Stacking

Thymalin stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from protocol designers.

Thymalin + BPC-157: Upregulates VEGFR2 to promote angiogenesis and activates the FAK-paxillin pathway for accelerated tissue repair. Pairs naturally with Thymalin's mechanism in protocol / scheduling / cycling protocols.
Thymalin + TB-500: Binds G-actin monomers and prevents their incorporation into F-actin filaments, regulating the cellular actin pool. Pairs naturally with Thymalin's mechanism in protocol / scheduling / cycling protocols.
Thymalin + Ipamorelin: Highly selective GHSR1a agonist. Pairs naturally with Thymalin's mechanism in protocol / scheduling / cycling protocols.
Thymalin + CJC-1295 without DAC (Mod GRF 1-29): Same GHRH-receptor agonism as DAC variant. Pairs naturally with Thymalin's mechanism in protocol / scheduling / cycling protocols.

Safety & Regulatory Status

WADA: Not on prohibited list FDA: Unapproved (used in Russia) Research: Decades of Russian clinical data

Excellent. Long human safety record.

Lens-specific safety considerations for protocol / scheduling / cycling use of Thymalin: Excellent. Long human safety record. Additional protocol / scheduling / cycling monitoring at baseline and 6–8 week follow-up is appropriate.

Clinical Evidence

Primary

Khavinson peptide bioregulators

PMID 12937674

Thymalin vs Related Peptides

Compound	Profile	Onset	Best For
Thymalin	Thymic polypeptide extract	Variable	Protocol
BPC-157	Stable gastric pentadecapeptide	~4 hr (oral)	Accelerated tendon, ligament, and gut tissue repair via VEGFR2-driven angiogenesis and FAK-paxillin signalling
TB-500	Synthetic thymosin β4 fragment	~2-3 days	A 17-amino-acid synthetic fragment of thymosin β4 with actin-sequestering activity — drives cell migration, tissue repair, and broad regenerative effects
Ipamorelin	Selective GHRP / ghrelin mimetic	~2 hr	The most selective ghrelin-receptor agonist among the GHRPs — stimulates GH release with minimal effect on cortisol, prolactin, or appetite
GHK-Cu	Tripeptide-copper complex	~30 min plasma	A naturally occurring tripeptide-copper complex that declines with age and is studied for its broad effects on wound healing, skin remodelling, and gene expression

Frequently Asked Questions

Best practice for re-cycling?

Run baseline labs before each cycle. Compare to prior cycle. Adjust dose downward if response is maintained; adjust upward only if response is incomplete and labs support the safety margin. Long-term cycle records inform protocol drift over years.

When to integrate Thymalin into an existing stack?

Add one new compound at a time, with at least 2 weeks of isolated dosing to establish individual response, before layering additional compounds. This approach prevents stack complexity from masking individual contributions and makes troubleshooting tractable.

Can I shift my schedule with travel?

Up to ±8 hours of timing shift has no clinical effect for most peptide schedules. Time-zone changes longer than 8 hours warrant a minor schedule adjustment over 1–2 days to re-anchor the cycle. Cold-chain requirements during travel are the more important operational concern.

What if I miss a dose?

Single missed doses are not consequential for most peptide schedules. Resume the next scheduled dose; do not double-dose. Multiple consecutive missed doses (3+) effectively start an off-period and warrant re-evaluating cycle progress before resuming.

What is Thymalin?

Thymalin (also known as Thymus extract polypeptide complex) is a small thymic polypeptide extract with a molecular weight of Polypeptide complex and a plasma half-life of Variable. Influences T-cell maturation and immune function. Modulates expression of thymic-derived cytokines. Part of Khavinson's broader peptide bioregulator framework for tissue-specific transcriptional regulation. The compound is studied primarily in the protocol / scheduling / cycling domain for the applications outlined above.

What should I look for in Thymalin sourcing and quality?

Acceptable Thymalin certificates of analysis specify: lot-specific (not template) issuance, HPLC purity ≥98%, mass spec confirmation matching Polypeptide complex, endotoxin testing for injectable routes, and third-party accredited laboratory issuance. Template COAs, missing endotoxin data, or vendor-internal labs are red flags. Pharmaceutical-grade compounded material is the lowest-risk supply path where accessible.

Clinical Protocol

Start a Thymalin Protocol

Alukard provides physician-supervised peptide protocols with GMP-certified Thymalin and GMP-certified compounds with personalised cycle design.

Get Protocol

Quick Facts

Molecular weight: Polypeptide complex
Half-life: Variable
WADA: Not on prohibited list
FDA: Unapproved (used in Russia)
Research: Decades of Russian clinical data

Stack Partners

BPC-157

TB-500

Ipamorelin

CJC-1295 without DAC (Mod GRF 1-29)

Semax

Research Note

All protocol / scheduling / cycling applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for Thymalin unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.

Physician-supervised peptide protocols

Start Your Protocol / Scheduling / Cycling Protocol for Thymalin

Alukard provides physician-supervised peptide protocols with GMP-certified compounds with personalised cycle design.

Get a Physician Consultation View All Compounds

HIPAA Compliant · GMP Certified · Physician Supervised